PubMed Health⌕ Search

PubMed · 15723662

Mutation at high rates reduces spatial structure within populations.

Abstract

The question of whether or not the high rates (mu) of mutation that occur for some hypervariable markers can affect commonly used empirical measures of spatial structure of genetic variation within populations is addressed. The results show that values of these measures are approximately halved when mu is 10(-2). Finest spatial-scale correlations, measured by either Moran's I-statistics or conditional kinship, are reduced by 30%-50%. When the mutation rate is 10 times lower, much smaller reductions result, e.g. averaging 7% for the finest scale correlations. Still smaller orders of magnitude of mu cause negligible changes in spatial structure, where any effects normally would not be detectable. The reductions are caused by forward mutations, and when the reductions are measured as percentages, they are nearly independent of the amount of structure produced sans mutation, except when dispersal is nearly minimal. The percent reductions are also nearly independent of the number of alleles and of back mutations, hence of the nature of the mutation process (e.g. stepwise or not). The results demonstrate that some hypervariable loci should have reduced spatial structuring, and that marker choice may affect the values observed in experimental surveys. Moreover, if fine-scale correlations are used to indirectly estimate dispersal distances, then mutation at high rates could inflate estimates, easily up to two- to three-fold.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bryan K Epperson. 2005. Mutation at high rates reduces spatial structure within populations.. https://doi.org/10.1111/j.1365-294x.2005.02429.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Generating correlated data for omics simulation.

Simulation of realistic omics data is a key input for benchmarking studies that help users obtain optimal computational pipelines. Omics data involves large numbers of measured features on each sample and these measures are generally correlated with each other. However, simulation too often ignores these correlations, perhaps due to computational and statistical hurdles of doing so. To alleviate this, we describe three approaches for generating omics-scale data with correlated measures which mimic real datasets. These approaches are all based on a Gaussian copula approach with a covariance matrix that decomposes into a diagonal part and a low-rank part. This decomposition allows for extremely efficient simulation, overcoming a hurdle for adoption of past methods. We use these approaches to demonstrate the importance of including correlation in two benchmarking applications. First, we show that variance of results from the popular DESeq2 method increases when dependence is included. Second, we demonstrate that CYCLOPS, a method for inferring circadian time of collection from transcriptomics, improves in performance when given gene-gene dependencies in some circumstances. We provide an R package, dependentsimr, that has efficient implementations of these methods and can generate dependent data with arbitrary marginal distributions, including discrete (binary, ordered categorical, Poisson, negative binomial), continuous (normal), or with an empirical distribution.

Computer Simulation↗

Addressing current challenges in cancer immunotherapy with mathematical and computational modelling.

The goal of cancer immunotherapy is to boost a patient's immune response to a tumour. Yet, the design of an effective immunotherapy is complicated by various factors, including a potentially immunosuppressive tumour microenvironment, immune-modulating effects of conventional treatments and therapy-related toxicities. These complexities can be incorporated into mathematical and computational models of cancer immunotherapy that can then be used to aid in rational therapy design. In this review, we survey modelling approaches under the umbrella of the major challenges facing immunotherapy development, which encompass tumour classification, optimal treatment scheduling and combination therapy design. Although overlapping, each challenge has presented unique opportunities for modellers to make contributions using analytical and numerical analysis of model outcomes, as well as optimization algorithms. We discuss several examples of models that have grown in complexity as more biological information has become available, showcasing how model development is a dynamic process interlinked with the rapid advances in tumour-immune biology. We conclude the review with recommendations for modellers both with respect to methodology and biological direction that might help keep modellers at the forefront of cancer immunotherapy development.

Computer Simulation↗

Degradation of supercoiled plasmid DNA within a capillary device.

Supercoiled plasmid DNA is susceptible to fluid stress in large-scale manufacturing processes. A capillary device was used to generate controlled shear conditions and the effects of different stresses on plasmid DNA structure were investigated. Computational fluid dynamics (CFD) analysis was employed to characterize the flow environment in the capillary device and different analytical techniques were used to quantify the DNA breakage. It was found that the degradation of plasmid DNA occurred at the entrance of the capillary and that the shear stress within the capillary did not affect the DNA structure. The degradation rate of plasmids was well correlated with the average elongational strain rate or the pressure drop at the entrance region. The conclusion may also be drawn that laminar shear stress does not play a significant role in plasmid DNA degradation.

Computer Simulation↗